| Name | Title | Contact Details |
|---|
OSG-Global is a Des Plaines, IL-based company in the Business Services sector.
Custom Automated Plastic Systems, Inc. (C.A.P.S Inc.) is the industry leader in designing and manufacturing injection molded plastic caps, closures and custom plastic packaging.
Eventgenuity, LLC is a Nashville, TN-based company in the Business Services sector.
Catholic Charities, Archdiocese of San Antonio is a nonprofit organization focused on serving the San Antonio community and nearby areas through a variety of social services. Its mission emphasizes compassionate support for all individuals, regardless of their background, from birth to natural death. The organization provides essential services, including emergency assistance with food and financial support, housing and shelter for the homeless, and legal aid for low-income immigrants. It also offers counseling and behavioral health services, family and childrens programs, and support for seniors. Additionally, Catholic Charities engages in community enrichment through tax preparation assistance, education programs, and employment services. The organization actively supports refugees and runs special initiatives to address specific community needs. Operating Monday through Friday, Catholic Charities encourages community involvement through volunteer opportunities and donation drives. Its comprehensive approach reflects a commitment to dignity, compassion, and holistic support for vulnerable populations in the region.
Sequel Med Tech is a healthcare technology company based in Manchester, New Hampshire, dedicated to advancing drug delivery systems for diabetes management. The company focuses on creating innovative insulin delivery solutions that enhance the lives of people with diabetes. Their flagship product, the twiist™ Automated Insulin Delivery (AID) System, features advanced technology for precise insulin delivery and is designed for everyday wear. This system utilizes the Loop algorithm to automatically adjust insulin delivery, providing clinically meaningful benefits. Sequel Med Tech collaborates with healthcare providers, employers, and pharmaceutical companies to improve access to insulin therapy and develop new drug delivery solutions. They are actively working on integrating their twiist AID System with Abbott’s glucose-ketone sensor to enhance early detection of rising ketones, aiming to reduce the risk of diabetic ketoacidosis in individuals with type 1 diabetes. Through these efforts, Sequel Med Tech strives to simplify diabetes care and improve health outcomes for those who require insulin therapy.